Researchers funded by NIH will now be required to make their scientific papers available to read for free as soon as they are published in a peer-reviewed journal.
In a move that will have direct impact on approval of cancer drugs, George Francis Tidmarsh, an oncologist and a longtime pharmaceutical executive, was named director of the FDA Center for Drug Evaluation and Research.
